WAT logo

Waters Corporation Stock Price

NYSE:WAT Community·US$22.4b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 19 Fair Values set on narratives written by author

WAT Share Price Performance

US$378.62
10.12 (2.75%)
US$424.46
Fair Value
US$378.62
10.12 (2.75%)
10.8% undervalued intrinsic discount
US$424.46
Fair Value
Price US$378.62
AnalystHighTarget US$424.46
AnalystLowTarget US$300.00
AnalystConsensusTarget US$382.87

WAT Community Narratives

AnalystHighTarget·
Fair Value US$424.46 10.8% undervalued intrinsic discount

LC-MS And Biotech Expansion Will Unlock Secular Healthcare Demand

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystLowTarget·
Fair Value US$300 26.2% overvalued intrinsic discount

Pharma Cost Pressures Will Erode Value But Foster Adaptation

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystConsensusTarget·
Fair Value US$382.87 1.1% undervalued intrinsic discount

Emerging Technologies And Share Repurchases Will Support Long-Term Market Opportunities

0users have liked this narrative
0users have commented on this narrative
11users have followed this narrative
US$382.87
1.1% undervalued intrinsic discount
Revenue growth
15.45% p.a.
Profit Margin
22.77%
Future PE
26.51x
Share price in 2028
US$480.54
US$424.46
10.8% undervalued intrinsic discount
Revenue growth
6.99% p.a.
Profit Margin
25.08%
Future PE
33.13x
Share price in 2028
US$516.83
US$300
26.2% overvalued intrinsic discount
AnalystLowTarget Fair Value
Revenue growth
5.9% p.a.
Profit Margin
25.87%
Future PE
23.41x
Share price in 2028
US$365.26

Updated Narratives

WAT logo

Emerging Technologies And Share Repurchases Will Support Long-Term Market Opportunities

Fair Value: US$382.87 1.1% undervalued intrinsic discount
11 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
WAT logo

Pharma Cost Pressures Will Erode Value But Foster Adaptation

Fair Value: US$300 26.2% overvalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
WAT logo

LC-MS And Biotech Expansion Will Unlock Secular Healthcare Demand

Fair Value: US$424.46 10.8% undervalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Solid track record with excellent balance sheet.

1 Risk
2 Rewards

Waters Corporation Key Details

US$3.1b

Revenue

US$1.3b

Cost of Revenue

US$1.8b

Gross Profit

US$1.2b

Other Expenses

US$648.8m

Earnings

Last Reported Earnings
Sep 27, 2025
Next Reporting Earnings
n/a
10.90
58.96%
20.89%
62.7%
View Full Analysis

About WAT

Founded
1958
Employees
7600
CEO
Udit Batra
WebsiteView website
www.waters.com

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.

Recent WAT News & Updates

Recent updates

No updates